The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Amid Trump’s dismantling of DEI, Roche wiped diversity targets from the website of its US subsidiary, Genentech, in mid-February. Basel-based competitor Novartis also said this week it was getting rid ...

Lebanon County crews responded to two fires within three miles of each other on Thursday night. The first blaze sparked ...

The Pennsylvania Department of Health is collecting information from anyone who dined at the restaurant in Adams County on or ...

Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...

NVS reports new safety and efficacy data from the phase III program for its investigational OAV101 IT gene therapy for SMA ...

Investing.com -- Morgan Stanley upgraded its rating on Zealand Pharma (NASDAQ: ZEAL) shares to Overweight from Equal Weight, ...